Parathyroid hormone

A double-edged sword for bone metabolism

Ling Qin, Liza J. Raggatt, Nicola Partridge

Research output: Contribution to journalArticle

Abstract

Parathyroid hormone (PTH) is the major hormone regulating calcium metabolism. It is also the only FDA-approved drug for osteoporosis treatment that stimulates bone formation when injected daily. However, continuous infusion of PTH causes severe bone loss in line with its known catabolic effects. Many studies to understand the dual effects of PTH have been carried out, and in recent years a growing number of molecular and cellular mechanisms underlying these effects have emerged. Here, we outline the present knowledge and conclude that the kinetics of administration and subsequent signaling probably account for the divergent actions of the hormone.

Original languageEnglish (US)
Pages (from-to)60-65
Number of pages6
JournalTrends in Endocrinology and Metabolism
Volume15
Issue number2
DOIs
StatePublished - Mar 2004

Fingerprint

Parathyroid Hormone
Bone and Bones
Hormones
Osteogenesis
Osteoporosis
Calcium
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Parathyroid hormone : A double-edged sword for bone metabolism. / Qin, Ling; Raggatt, Liza J.; Partridge, Nicola.

In: Trends in Endocrinology and Metabolism, Vol. 15, No. 2, 03.2004, p. 60-65.

Research output: Contribution to journalArticle

@article{b154b1c5225840228cfed289c780d65c,
title = "Parathyroid hormone: A double-edged sword for bone metabolism",
abstract = "Parathyroid hormone (PTH) is the major hormone regulating calcium metabolism. It is also the only FDA-approved drug for osteoporosis treatment that stimulates bone formation when injected daily. However, continuous infusion of PTH causes severe bone loss in line with its known catabolic effects. Many studies to understand the dual effects of PTH have been carried out, and in recent years a growing number of molecular and cellular mechanisms underlying these effects have emerged. Here, we outline the present knowledge and conclude that the kinetics of administration and subsequent signaling probably account for the divergent actions of the hormone.",
author = "Ling Qin and Raggatt, {Liza J.} and Nicola Partridge",
year = "2004",
month = "3",
doi = "10.1016/j.tem.2004.01.006",
language = "English (US)",
volume = "15",
pages = "60--65",
journal = "Trends in Endocrinology and Metabolism",
issn = "1043-2760",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Parathyroid hormone

T2 - A double-edged sword for bone metabolism

AU - Qin, Ling

AU - Raggatt, Liza J.

AU - Partridge, Nicola

PY - 2004/3

Y1 - 2004/3

N2 - Parathyroid hormone (PTH) is the major hormone regulating calcium metabolism. It is also the only FDA-approved drug for osteoporosis treatment that stimulates bone formation when injected daily. However, continuous infusion of PTH causes severe bone loss in line with its known catabolic effects. Many studies to understand the dual effects of PTH have been carried out, and in recent years a growing number of molecular and cellular mechanisms underlying these effects have emerged. Here, we outline the present knowledge and conclude that the kinetics of administration and subsequent signaling probably account for the divergent actions of the hormone.

AB - Parathyroid hormone (PTH) is the major hormone regulating calcium metabolism. It is also the only FDA-approved drug for osteoporosis treatment that stimulates bone formation when injected daily. However, continuous infusion of PTH causes severe bone loss in line with its known catabolic effects. Many studies to understand the dual effects of PTH have been carried out, and in recent years a growing number of molecular and cellular mechanisms underlying these effects have emerged. Here, we outline the present knowledge and conclude that the kinetics of administration and subsequent signaling probably account for the divergent actions of the hormone.

UR - http://www.scopus.com/inward/record.url?scp=1342329522&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1342329522&partnerID=8YFLogxK

U2 - 10.1016/j.tem.2004.01.006

DO - 10.1016/j.tem.2004.01.006

M3 - Article

VL - 15

SP - 60

EP - 65

JO - Trends in Endocrinology and Metabolism

JF - Trends in Endocrinology and Metabolism

SN - 1043-2760

IS - 2

ER -